Brachytherapy Global Market Report 2025

Brachytherapy is a form of radiotherapy where radioactive sources are placed directly into or near the tumor, enabling targeted delivery of radiation to cancerous tissues while minimizing exposure to surrounding healthy tissues. It is widely used for treating cancers such as prostate, cervical, and skin cancers, providing a localized and effective treatment option.

The main types of brachytherapy include applicators and afterloaders, as well as electronic brachytherapy. Applicators are devices used to deliver radioactive sources directly to treatment sites, while afterloaders automate the process of placing these sources, ensuring precision and safety in brachytherapy treatments. Brachytherapy can be administered in high-dose rate (HDR) or low-dose rate (LDR), applied in treatments for prostate cancer, gynecological cancer, breast cancer, and various medical conditions. End users typically include hospitals, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The brachytherapy market research report is one of a series of new reports from The Business Research Company that provides brachytherapy market statistics, including the brachytherapy industry's global market size, regional shares, competitors with a brachytherapy market share, detailed brachytherapy market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy industry. This brachytherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The brachytherapy market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing cancer incidence, raising awareness and early detection efforts, growing awareness of brachytherapy's effectiveness and reduced side effects, favorable reimbursement policies in various regions, approval and standardization of brachytherapy procedures and devices.

The brachytherapy market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to tailoring treatments based on genetic and molecular profiles, increasing demand due to higher cancer incidence in elderly populations, expansion of healthcare facilities supporting brachytherapy, higher investments in cancer treatment, increasing preference for less invasive therapies. Major trends in the forecast period include innovation in brachytherapy techniques and equipment, personalized medicine, integration of advanced imaging technologies such as MRI and PET-CT for real-time guidance during brachytherapy procedures, growing preference for outpatient brachytherapy procedures, and advanced brachytherapy technology.

The forecast of 7.4% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for iridium-192 seeds and shielded applicator devices, sourced from key regions such as Canada and the Netherlands, which could lead to treatment delays for cancer patients and increased radiation therapy costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The projected increase in cancer burden is set to drive growth in the brachytherapy market. This rise in cancer cases is attributed to factors such as aging populations, changes in lifestyle, and heightened exposure to risk factors such as tobacco use, poor dietary habits, and environmental pollutants. Brachytherapy serves as a targeted and effective treatment option for managing cancer burden, offering localized therapy tailored to various cancer types, which helps minimize treatment duration and side effects. For example, the American Cancer Society reported in January 2022 that the US is expected to see approximately 1.9 million new cancer cases and 609,360 cancer-related deaths, highlighting a significant daily impact. Globally, lung, prostate, colorectal, and breast cancers are among the most prevalent, accounting for 43% of all newly diagnosed cases. Therefore, the escalating cancer burden is expected to stimulate growth in the brachytherapy market.

Key players in the brachytherapy market are concentrating on advancing technological solutions, such as standard afterloader technology, to improve treatment accuracy and effectiveness. Standard afterloader technology automates the delivery of radioactive sources to tumor sites during brachytherapy, ensuring precise administration of radiation doses. For instance, Varian Medical Systems, a US-based medical device manufacturer, collaborated with Maastro, a US-based radiotherapy clinic, to introduce a new brachytherapy applicator in April 2024. This innovative device, partially 3D-printed and co-developed by Maastro's radiation oncologists, physicists, and Varian experts, enhances HDR brachytherapy treatment for rectal cancer. The applicator is designed to enhance tumor contact and deliver a uniform dose distribution, comparable to contact X-ray brachytherapy (CXB).

In April 2024, GT Medical Technologies Inc., a US-based medical device manufacturer, acquired Cesium-131 and related assets from Isoray Medical to strengthen its supply chain and market position. This strategic acquisition underscores GT MedTech's commitment to expanding the adoption of GammaTile in the US, leveraging Cesium-131 brachytherapy seed manufacturing capabilities. Isoray Medical, also a US-based medical device manufacturer, specializes in brachytherapy products for cancer treatment.

Major companies operating in the brachytherapy market are Siemens Healthineers, Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Varian Medical Systems Inc., Carl Zeiss AG, Elekta, Argon Medical Devices Inc., Sirtex Medical Limited, Theragenics Corporation, RaySearch Laboratories, Nanobiotix SA, CIVCO Medical Solutions, Eckert Ziegler Bebig GmbH, iCAD Inc., IsoAid, C4 Imaging LLC, Mick Radio-Nuclear Instruments Inc., Huiheng Medical Inc., Best Medical International Inc., Cianna Medical Inc.

North America was the largest region in the brachytherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachytherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the brachytherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The brachytherapy market consists of revenues earned by entities by providing services such as treatment planning, procedure administration, and post-treatment care. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachytherapy market also includes sales of radioactive seeds, applicators, imaging and planning systems, and treatment delivery systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Brachytherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on brachytherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for brachytherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brachytherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Seeds; Applicators And Afterloaders; Electronic Brachytherapy
• 2) By Dosage Type: High-Dose Rate (HDR) Brachytherapy; Low-Dose Rate (LDR) Brachytherapy
• 3) By Application: Prostate Cancer; Gynecological Cancer; Breast Cancer; Other Applications
• 4) By End-User: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Seeds: Iodine-125 Seeds; Palladium-103 Seeds; Cesium-131 Seeds; Other Radioactive Seeds
• 2) By Applicators And Afterloaders: Prostate Applicators; Vaginal Applicators; Interstitial Applicators; Skin Applicators; Afterloaders
• 3) By Electronic Brachytherapy: Electronic Brachytherapy Units; Electronic Brachytherapy Sources
• Companies Mentioned: Siemens Healthineers; Becton Dickinson and Company; Boston Scientific Corporation; Hologic Inc.; Varian Medical Systems Inc.; Carl Zeiss AG; Elekta; Argon Medical Devices Inc.; Sirtex Medical Limited; Theragenics Corporation; RaySearch Laboratories; Nanobiotix SA; CIVCO Medical Solutions; Eckert Ziegler Bebig GmbH; iCAD Inc.; IsoAid; C4 Imaging LLC; Mick Radio-Nuclear Instruments Inc.; Huiheng Medical Inc.; Best Medical International Inc.; Cianna Medical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.